Literature DB >> 14639684

Treatment of Sydenham chorea with corticosteroids.

Francisco Cardoso1, Débora Maia, Mauro César Q S Cunningham, Guilherme Valença.   

Abstract

Despite treatment with valproic acid and neuroleptics, a significant proportion of patients with Sydenham chorea (SC) remain with chorea. We evaluated the effect of intravenous methyl-prednisolone followed by oral prednisone in patients with SC refractory to conventional treatment. Patients were enrolled in the study if they failed to improve with conventional treatment, despite the development of side effects. Chorea was rated on a 0 to 4 score. Five patients, 3 of them women, were included in the study. The median pretreatment rating score of the chorea was 3 (range, 3-4) and dropped to 1 (range, 0-2) after a median follow-up of 7 months (range, 3-7 months). Two patients developed Cushing syndrome. Our data suggest that intravenous methyl-prednisolone followed by oral prednisone is an effective and well-tolerated treatment of refractory SC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639684     DOI: 10.1002/mds.10521

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Progressive MRI abnormalities in late recurrence of Sydenham's chorea.

Authors:  C Moreau; D Devos; C Delmaire; C Gervais; L Defebvre; A Destée
Journal:  J Neurol       Date:  2005-06-28       Impact factor: 4.849

2.  Psychosis following acute Sydenham's chorea.

Authors:  Antônio Lúcio Teixeira; Débora Palma Maia; Francisco Cardoso
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-06-20       Impact factor: 4.785

Review 3.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

4.  Neuropsychological manifestations in children with Sydenham's chorea after adjunct intravenous immunoglobulin and standard treatment.

Authors:  Claire Gregorowski; Christine Lochner; Lindi Martin; Candice Simmons; Martin Kidd; Kathleen Walker; Jo M Wilmshurst; Soraya Seedat
Journal:  Metab Brain Dis       Date:  2015-05-19       Impact factor: 3.584

5.  Sydenham's Chorea.

Authors:  Francisco Cardoso
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

6.  Diffusion-weighted imaging in Sydenham's chorea.

Authors:  Hakan Gumus; Gulsum Gumus; Huseyin Per; Ali Yikilmaz; Mehmet Canpolat; Gamze Poyrazoglu; Nazmi Narin
Journal:  Childs Nerv Syst       Date:  2012-08-28       Impact factor: 1.475

7.  Gluten Ataxia and Post-Streptococcal Central Nervous System Syndromes: Emerging Immune-mediated Disorders of the Central Nervous System?

Authors:  Adrian Wills; Russell Dale; Gavin Giovannoni
Journal:  Curr Treat Options Neurol       Date:  2005-05       Impact factor: 3.972

8.  Beneficial use of immunoglobulins in the treatment of Sydenham chorea.

Authors:  Tabitha D van Immerzeel; Ruud M van Gilst; Nico G Hartwig
Journal:  Eur J Pediatr       Date:  2010-03-30       Impact factor: 3.183

Review 9.  Treatment of Sydenham's Chorea: A Review of the Current Evidence.

Authors:  Shannon L Dean; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-06-01

Review 10.  Autoimmune and Paraneoplastic Chorea: A Review of the Literature.

Authors:  Kevin Kyle; Yvette Bordelon; Nagagopal Venna; Jenny Linnoila
Journal:  Front Neurol       Date:  2022-03-18       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.